Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01521039 · ClinicalTrials.gov registry record
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease
A clinical trial, sponsored by Ohio State University Comprehensive Cancer Center.
- Completed
- Registry status
- 259
- Enrollment target
NCT01521039 is a clinical trial that has completed, run by Ohio State University Comprehensive Cancer Center. The registered enrollment target is 259 participants.
The verdict
NCT01521039 has completed, sponsored by Ohio State University Comprehensive Cancer Center.
- COMPLETED
- Registry status
- 259 participants
- Enrollment target
Study Summary
Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (GVHD).
Interventions
- PROCEDURE Blood samples
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 259 participants |
| Start Date | 2012-02-20 |
| Est. Completion | 2024-12-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01521039
The ClinicalTrials.gov registry entry for NCT01521039 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 259 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Ohio State University Comprehensive Cancer Center, which has 341 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Blood samples is the first listed.
NCT01521039 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01521039 about?
NCT01521039 is a clinical study titled "Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease". Assessment of MicroRNA Expression in Acute Graft-versus-Host Disease (GVHD).
What is the current status of trial NCT01521039?
This trial is currently completed. The enrollment target is 259 participants. The study started on 2012-02-20. Estimated completion is 2024-12-30.
What interventions are being tested in trial NCT01521039?
The interventions under investigation include: Blood samples (PROCEDURE).
Who is sponsoring clinical trial NCT01521039?
This trial is sponsored by Ohio State University Comprehensive Cancer Center, which has 341 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.